Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.2552
-0.0048 (-1.85%)
Mar 31, 2025, 10:55 AM EDT - Market open
Elevation Oncology Employees
Elevation Oncology had 34 employees as of December 31, 2024. The number of employees increased by 5 or 17.24% compared to the previous year.
Employees
34
Change (1Y)
5
Growth (1Y)
17.24%
Revenue / Employee
n/a
Profits / Employee
-$1,308,382
Market Cap
15.11M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34 | 5 | 17.24% |
| Dec 31, 2023 | 29 | -4 | -12.12% |
| Dec 31, 2022 | 33 | 10 | 43.48% |
| Dec 31, 2021 | 23 | 15 | 187.50% |
| Dec 31, 2020 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ELEV News
- 5 days ago - Elevation Oncology to Present Preclinical Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025 - PRNewsWire
- 10 days ago - Elevation Oncology Stops Gastric Cancer Study, Slashes Staff By 70% - Benzinga
- 11 days ago - Elevation Oncology to Discontinue Development of EO-3021; Advancing EO-1022, While Evaluating Strategic Options - PRNewsWire
- 24 days ago - Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Achievements - PRNewsWire
- 4 weeks ago - Elevation Oncology to Participate in Upcoming Investor Conferences - PRNewsWire
- 2 months ago - Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones - PRNewsWire
- 3 months ago - Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors - PRNewsWire
- 3 months ago - Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline Expansion - PRNewsWire